US 8,617,595 · Application 10/590,398
US Patent 8,617,595 — assignment history and current owner
Galenic Formulations Of Organic Compounds
Who owns US Patent 8,617,595?
US8617595 ("Galenic Formulations Of Organic Compounds") — current assignee: NODEN PHARMA DAC. Status: Expired. 8 recorded USPTO assignments.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 8,617,595 is NODEN PHARMA DAC. Based on the most recent ownership transfer record (recorded 2016-07-26).
- Patent title
- Galenic Formulations Of Organic Compounds
- Application number
- 10/590,398
- Apparent operating assignee
- NODEN PHARMA DAC
- Patent status
- Expired
- Recorded assignments
- 8
Note: a security interest appears active (KROLL TRUSTEE SERVICES LIMITED, AS SECURITY AGENT) with no recorded release. Security interests reflect financing arrangements, not operating ownership.
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Jul 1, 2016 | Jul 26, 2016 | Ownership Transfer | NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG | NODEN PHARMA DAC | 39481/233 |
| Jul 1, 2016 | Aug 29, 2016 | Corrective Assignment | NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG | NODEN PHARMA DAC | 40003/579 |
| Aug 29, 2016 | Mar 21, 2017 | Other | NODEN PHARMA DAC | NODEN PHARMA DAC | 42084/980 |
| Nov 6, 2020 | Nov 9, 2020 | Security Interest | NODEN PHARMA DESIGNATED ACTIVITY COMPANY | GLAS TRUST CORPORATION LIMITED | 54316/730 |
| Sep 30, 2022 | Sep 30, 2022 | Security Interest | NODEN PHARMA DESIGNATED ACTIVITY COMPANY | KROLL TRUSTEE SERVICES LIMITED, AS SECURITY AGENT | 61271/832 |
| Jan 13, 2026 | Jan 13, 2026 | Release of Security Interest | KROLL TRUSTEE SERVICES LIMITED | LXO IRELAND DESIGNATED ACTIVITY COMPANY (PREVIOUSLY NODEN PHARMA DESIGNATED ACTIVITY COMPANY) | 73455/590 |
| Apr 10, 2026 | Apr 27, 2026 | Security Interest | LXO IRELAND DESIGNATED ACTIVITY COMPANY | KROLL TRUSTEE SERVICES LIMITED, AS SECURITY AGENT | 74483/163 |
| Apr 23, 2026 | Apr 28, 2026 | Release of Security Interest | GLAS TRUST CORPORATION LIMITED | NODEN PHARMA DESIGNATED ACTIVITY COMPANY | 74502/879 |
Scrolls sideways on narrow screens
Chain of title
In 2016, NOVARTIS AG; NOVARTIS PHARMA AG (+1 more) assigned the patent to NODEN PHARMA DAC. In 2022, KROLL TRUSTEE SERVICES LIMITED, AS SECURITY AGENT recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
The prosecution record for your AI
Application 10/590,398 · US 8,617,595
Ownership settled? Give your AI the file.
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 8,617,595, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.